TR200003064T2 - Yeni bileşik - Google Patents

Yeni bileşik

Info

Publication number
TR200003064T2
TR200003064T2 TR2000/03064T TR200003064T TR200003064T2 TR 200003064 T2 TR200003064 T2 TR 200003064T2 TR 2000/03064 T TR2000/03064 T TR 2000/03064T TR 200003064 T TR200003064 T TR 200003064T TR 200003064 T2 TR200003064 T2 TR 200003064T2
Authority
TR
Turkey
Prior art keywords
pneumocystis carinii
activity
new compound
beta
animal
Prior art date
Application number
TR2000/03064T
Other languages
English (en)
Inventor
Ohki Hidenori
Murano Kenji
Tojo Takashi
Shiraishi Nobuyuki
Matsuya Takahiro
Matsuda Hiroshi
Mizuno Hiroaki
Barrett David
Matsuda Keiji
Kawabata Kohji
Original Assignee
Fujisawa Pharmaceutical Co; Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP1728A external-priority patent/AUPP172898A0/en
Priority claimed from AUPP3138A external-priority patent/AUPP313898A0/en
Application filed by Fujisawa Pharmaceutical Co; Ltd. filed Critical Fujisawa Pharmaceutical Co; Ltd.
Publication of TR200003064T2 publication Critical patent/TR200003064T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu bulus,genel formül (I) ile temsil edilen ve antimikrobiyal akyiviteye (özellikle fungus önleyici aktiviteye), Beta-1,3-glukan sentaz üzerinde inhibe edici aktiviteye sahip yeni polipeptid bilesikleri (burada R1,R2,R3 ve R4 tarifnamede tanimlandigi gibidir) veya bunlarin bir tuzu, bunlari hazirlamak için yöntemler, bunlari ihtiva eden farmasötik terkip ve bir insanda veya bir hayvanda, Pneumocystis carinii enfeksiyonu (örn.Pneumocystis carinii pnömonisi) dahil bulasici hastaliklarin önlenmesi veya tedavi edilmesi için bir yöntemle ilgilidir.
TR2000/03064T 1998-02-09 1999-02-05 Yeni bileşik TR200003064T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP1728A AUPP172898A0 (en) 1998-02-09 1998-02-09 New compound
AUPP3138A AUPP313898A0 (en) 1998-04-23 1998-04-23 New compound

Publications (1)

Publication Number Publication Date
TR200003064T2 true TR200003064T2 (tr) 2001-02-21

Family

ID=25645713

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03064T TR200003064T2 (tr) 1998-02-09 1999-02-05 Yeni bileşik

Country Status (13)

Country Link
US (1) US6232290B1 (tr)
EP (1) EP1053247A1 (tr)
JP (2) JP3561917B2 (tr)
KR (1) KR100396737B1 (tr)
CN (1) CN1240713C (tr)
AR (1) AR014554A1 (tr)
BR (1) BR9907967A (tr)
CA (1) CA2320416A1 (tr)
HU (1) HUP0102515A3 (tr)
IL (1) IL137494A0 (tr)
NO (1) NO20003996L (tr)
TR (1) TR200003064T2 (tr)
WO (1) WO1999040108A1 (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU767956B2 (en) * 1999-03-03 2003-11-27 Eli Lilly And Company Formation and anion-exchange of crystalline echinocandin ammonium salts
AUPP999799A0 (en) 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
TWI250992B (en) 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
US7208503B2 (en) * 2000-04-21 2007-04-24 Janssen Pharmaceutica N.V. Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
US6316475B1 (en) * 2000-11-17 2001-11-13 Abbott Laboratories Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications
AUPR362001A0 (en) * 2001-03-08 2001-04-05 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPS044102A0 (en) * 2002-02-11 2002-03-07 Fujisawa Pharmaceutical Co., Ltd. New compound
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
AU2003903629A0 (en) * 2003-07-14 2003-07-31 Fujisawa Pharmaceutical Co., Ltd. New compound
EP2402323A3 (en) * 2004-10-13 2012-05-30 PTC Therapeutics, Inc. Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
WO2006131336A1 (en) * 2005-06-08 2006-12-14 Novartis Ag POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
WO2007009083A2 (en) * 2005-07-12 2007-01-18 Acadia Pharmaceuticals Inc. Compounds with activity at retinoic acid receptors
EP1902022A1 (en) * 2005-07-12 2008-03-26 Glaxo Group Limited Piperazine heteroaryl derivates as gpr38 agonists
JP5222561B2 (ja) * 2005-10-07 2013-06-26 キッセイ薬品工業株式会社 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
AU2008286879B2 (en) 2007-08-13 2013-08-22 Monsanto Technology Llc Compositions and methods for controlling nematodes
CN101861330A (zh) 2007-10-29 2010-10-13 安斯泰来制药有限公司 多肽化合物
JP5387567B2 (ja) 2008-03-14 2014-01-15 アステラス製薬株式会社 環状化合物およびその塩
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
CA2761595A1 (en) * 2009-05-14 2010-11-18 Astellas Pharma Inc. Polyketide compound
US9353072B2 (en) * 2012-10-31 2016-05-31 Purdue Research Foundation Antimicrobial substituted thiazoles and methods of use
WO2019207413A1 (en) 2018-04-25 2019-10-31 Universidad De La República (Udelar) Cyclic hexapeptides compounds with anti-malarial activity
WO2020210831A1 (en) * 2019-04-12 2020-10-15 TONIX Pharmaceuticals Holding Corp Inhibitors of cd40-cd154 binding

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE990233A1 (en) 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
AU681119B2 (en) * 1993-05-17 1997-08-21 Fujisawa Pharmaceutical Co., Ltd. New polypeptide compound and a process for preparation thereof
WO1996011210A1 (en) * 1994-10-07 1996-04-18 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides having antibiotic activity
US5629289A (en) * 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents

Also Published As

Publication number Publication date
JP3561917B2 (ja) 2004-09-08
CN1296494A (zh) 2001-05-23
IL137494A0 (en) 2001-07-24
HUP0102515A3 (en) 2001-12-28
NO20003996D0 (no) 2000-08-08
WO1999040108A1 (en) 1999-08-12
AR014554A1 (es) 2001-02-28
NO20003996L (no) 2000-10-09
JP2001522377A (ja) 2001-11-13
US6232290B1 (en) 2001-05-15
BR9907967A (pt) 2000-10-17
CA2320416A1 (en) 1999-08-12
JP2004067699A (ja) 2004-03-04
EP1053247A1 (en) 2000-11-22
CN1240713C (zh) 2006-02-08
KR100396737B1 (ko) 2003-09-13
HUP0102515A2 (hu) 2001-11-28

Similar Documents

Publication Publication Date Title
TR200003064T2 (tr) Yeni bileşik
BR0210344A (pt) Inibidores da hiv protease, composições contendo os mesmos, seus usos farmacêuticos e materiais para a sua sìntese
MX9702531A (es) Compuesto nuevo.
NO971471L (no) Nye karboksamider med fungicid aktivitet
ES2066120T3 (es) Uso de derivados de bencimidazol como agentes antibacterianos.
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
ES2172585T3 (es) Derivado de benzoimidazol.
BR0207809A (pt) Compostos heteroarila contendo nitrogênio possuindo atividade inibidora contra integrase de hiv
BR0314188A (pt) Acetil 2-hidróxi-1,3-diaminoalcanos
AU2001272735A1 (en) Novel physiologically active peptide and use thereof
BR0214736A (pt) Composto e seus sais farmaceuticamente aceitáveis, composição farmacêutica e método de tratar seres humanos ou animais que sofrem de doenças ou condições
BR0016605A (pt) Oxazolidinonas possuindo uma funcionalidade sulfoximina e seus usos como agente antimicrobiano
NO20075749L (no) 1H-Quinazoline-2,4-diones and their use as ampa-receptor ligands
NO20005813L (no) Forsterking av aktiviteten til antibakterielle oksazolidinonmidler ved anvendelse av argininderivater
BR0016742A (pt) Compostos e composições antipicorna virais, suas aplicações farmacêuticas, e materiais para sua sìntese
EP0932613A4 (en) EXPRESSION BLOCKING OF VIRULENT FACTORS IN S. AUREUS
WO2002072621A3 (en) Cyclohexapeptide having antimicrobial activity
ES2151600T3 (es) Derivados de n-(3-amino-2-hidroxibutil)sulfonamida utilizados como inhibidores de proteasa de vih.
BR0214359A (pt) Método para tratar ou prevenir o mal de alzheimer e uma doença e para tratar um paciente que tem, ou para prevenir que um paciente adquira uma doença ou condição, para inibir a atividade de beta-secretase, a clivagem de um isotipo de proteìna de precursor amilóide e a produção de peptìdeo e de placa beta-amilóide e para produzir um complexo de beta-secretase, uso de um composto e, composição
CY1105449T1 (el) Μια τυποποιηση υδατινου διαλυματος αλφα-ιντepφepονης
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
TR200003065T2 (tr) Nöraminidazların inhibitörleri olarak pirolidinler.
BR9915671A (pt) Compostos de organofósforo e uso dos mesmos